Kratz; Felix

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kratz; Felix.The latest application filed is for "imaging agents for radiolabeling exogenous and endogenous albumin".

Company Profile

3.30.29

Kratz; Felix - Ehrenkirchen DE
Kratz; Felix - Ihringen N/A DE
Kratz; Felix - Freiburg DE
Kratz; Felix - Ihringer DE
Kratz; Felix - 79232 Maseh DE
Kratz; Felix - D-79232 March DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Delivery systems for controlled drug release Grant 11,384,104 - Kratz , et al. July 12, 2	2022-07-12
Albumin-binding prodrugs of auristatin E derivatives Grant 11,377,473 - Kratz , et al. July 5, 2	2022-07-05
Imaging Agents For Radiolabeling Exogenous And Endogenous Albumin App 20210353783 - Kratz; Felix ; et al.	2021-11-18
Albumin-binding Prodrugs Of Auristatin E Derivatives App 20200385421 - Kratz; Felix ; et al.	2020-12-10
Maytansinoid-based Drug Delivery Systems App 20200385403 - Kratz; Felix ; et al.	2020-12-10
Combination of drugs with protein-binding prodrugs Grant 10,426,841 - Kratz October 1, 2	2019-10-01
Combination of drugs with protein-binding prodrugs Grant 10,220,101 - Kratz	2019-03-05
Delivery Systems For Controlled Drug Release App 20190002484 - Kratz; Felix ; et al.	2019-01-03
Dual acting prodrugs Grant 9,901,644 - Kratz , et al. February 27, 2	2018-02-27
Combinations Of Albumin-Based Drug Delivery Systems App 20180028679 - Kratz; Felix ; et al.	2018-02-01
Combination Of Drugs With Protein-Binding Prodrugs App 20170319707 - KRATZ; Felix	2017-11-09
Combinations of albumin-based drug delivery systems Grant 9,801,949 - Kratz , et al. October 31, 2	2017-10-31
Dual Acting Prodrugs App 20160346396 - KRATZ; Felix ; et al.	2016-12-01
Dual acting prodrugs Grant 9,446,138 - Kratz , et al. September 20, 2	2016-09-20
Bisphosphonate-prodrugs Grant 9,320,803 - Kratz , et al. April 26, 2	2016-04-26
Receptor and antigen targeted prodrug Grant 9,216,228 - Kratz December 22, 2	2015-12-22
Process For Producing An Injectable Medicament Preparation App 20150196573 - Kratz; Felix	2015-07-16
Combinations Of Albumin-based Drug Delivery Systems App 20150023912 - Kratz; Felix ; et al.	2015-01-22
Process for producing an injectable medicament preparation Grant 8,846,602 - Kratz September 30, 2	2014-09-30
Dual Acting Prodrugs App 20140205539 - Kratz; Felix ; et al.	2014-07-24
Bisphosphonate-prodrugs Grant 8,778,914 - Kratz , et al. July 15, 2	2014-07-15
Low-viscous anthracycline formulation Grant 8,703,724 - Kratz April 22, 2	2014-04-22
Dual acting prodrugs Grant 8,664,181 - Kratz , et al. March 4, 2	2014-03-04
Bisphosphonate-Prodrugs App 20140051623 - Kratz; Felix ; et al.	2014-02-20
Prodrugs Grant 8,642,555 - Kratz , et al. February 4, 2	2014-02-04
Combination Of Drugs With Protein-Binding Prodrugs App 20130040905 - Kratz; Felix	2013-02-14
Process For Producing An Injectable Medicament Preparation App 20120195832 - Kratz; Felix	2012-08-02
Bisphosphonate-prodrugs App 20120165296 - Kratz; Felix ; et al.	2012-06-28
Prodrugs App 20120094892 - Kratz; Felix ; et al.	2012-04-19
Process for producing an injectable medicament preparation Grant 8,153,581 - Kratz April 10, 2	2012-04-10
Drug Conjugates With Polyglycerols App 20110117009 - Kratz; Felix ; et al.	2011-05-19
Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same Grant 7,902,144 - Kratz March 8, 2	2011-03-08
Protein-binding doxorubicin peptide derivatives Grant 7,803,903 - Kratz September 28, 2	2010-09-28
Process For Producing An Injectable Medicament Preparation App 20100215574 - KRATZ; FELIX	2010-08-26
Low-viscous Anthracycline Formulation App 20100152273 - Kratz; Felix	2010-06-17
Dual Acting Prodrugs App 20100144647 - Kratz; Felix ; et al.	2010-06-10
Receptor and Antigen Targeted Prodrug App 20100111866 - Kratz; Felix	2010-05-06
Protein-binding Methotrexate Derivatives, And Medicaments Containing The Same App 20100041615 - Kratz; Felix ; et al.	2010-02-18
Carrier-drug conjugate Grant 7,445,764 - Kratz November 4, 2	2008-11-04
Protein-Binding Anthracycline Peptide Derivatives and Drugs Containing Them App 20080161245 - Kratz; Felix ; et al.	2008-07-03
Method for producing an injectable medicament preparation Grant 7,387,771 - Kratz June 17, 2	2008-06-17
Protein-bound derivatives of platinum complexes containing cyclobutane1, 1-dicarboxyllate ligands Grant 7,141,691 - Kratz , et al. November 28, 2	2006-11-28
Process for producing an injectable medicament preparation App 20060233707 - Kratz; Felix	2006-10-19
Protein-binding doxorubicin peptide derivatives App 20060173161 - Kratz; Felix	2006-08-03
Protein-bound derivatives of platinum complexes containing cyclobutane1,1-dicarboxyllate ligands App 20060089341 - Kratz; Felix ; et al.	2006-04-27
Antineoplastic conjugates of transferin, albumin and polyethylene glycol Grant 6,709,679 - Kratz March 23, 2	2004-03-23
Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same App 20030185793 - Kratz, Felix	2003-10-02
Antineoplastic conjugates of transferrin, albumin and polyethylene glycol App 20020019343 - Kratz, Felix	2002-02-14
Antineoplastic conjugates of transferrin, albumin and polyethylene glycol Grant 6,310,039 - Kratz October 30, 2	2001-10-30

Company Registrations

SEC

0001726224

Kratz Felix

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.